Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

AstraZeneca PLC ADR, Common Stock

AZN

NSQ

$76.35

+$0.55

(0.73%)

Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$236.72B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

37.61

Volume

This is the total number of shares traded during the most recent trading day.

9.03M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

6.70M

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

1.9%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.19

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$59.55 L

$76.8 H

$76.35

About AstraZeneca PLC ADR, Common Stock

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time Frame	AZN	Sector	S&P500
1-Week Return	1.6%	0.37%	-0.64%
1-Month Return	14.31%	-2.46%	-2.75%
3-Month Return	19.04%	-1.01%	2.89%
6-Month Return	21.24%	11.15%	17.07%
1-Year Return	4.64%	6.99%	25.71%
3-Year Return	52.17%	19.96%	26.45%
5-Year Return	125.35%	69.86%	86.7%
10-Year Return	166.26%	183.96%	222.9%

Time Frame	AZN	Sector	S&P500
1-Week Return	128.80%	21.24%	-28.45%
1-Month Return	408.97%	-26.14%	-28.77%
3-Month Return	102.76%	-4.03%	12.25%
6-Month Return	47.78%	23.91%	37.66%
1-Year Return	4.64%	6.99%	25.71%
3-Year Return	15.02%	6.25%	8.14%
5-Year Return	17.64%	11.18%	13.30%
10-Year Return	10.29%	11.00%	12.44%

Financials

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	24.38B	26.62B	37.42B	44.35B	45.81B	[{"date":"2019-12-31","value":53.23,"profit":true},{"date":"2020-12-31","value":58.1,"profit":true},{"date":"2021-12-31","value":81.68,"profit":true},{"date":"2022-12-31","value":96.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	4.92B	5.30B	12.44B	12.39B	8.27B	[{"date":"2019-12-31","value":39.57,"profit":true},{"date":"2020-12-31","value":42.61,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.63,"profit":true},{"date":"2023-12-31","value":66.48,"profit":true}]
Gross Profit	19.46B	21.32B	24.98B	31.96B	37.54B	[{"date":"2019-12-31","value":51.84,"profit":true},{"date":"2020-12-31","value":56.78,"profit":true},{"date":"2021-12-31","value":66.54,"profit":true},{"date":"2022-12-31","value":85.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	79.82%	80.09%	66.76%	72.06%	81.95%	[{"date":"2019-12-31","value":97.4,"profit":true},{"date":"2020-12-31","value":97.73,"profit":true},{"date":"2021-12-31","value":81.46,"profit":true},{"date":"2022-12-31","value":87.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	16.27B	16.16B	23.92B	28.20B	28.82B	[{"date":"2019-12-31","value":56.43,"profit":true},{"date":"2020-12-31","value":56.06,"profit":true},{"date":"2021-12-31","value":83.01,"profit":true},{"date":"2022-12-31","value":97.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	2.92B	5.16B	1.06B	3.76B	8.19B	[{"date":"2019-12-31","value":35.69,"profit":true},{"date":"2020-12-31","value":63.01,"profit":true},{"date":"2021-12-31","value":12.89,"profit":true},{"date":"2022-12-31","value":45.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	(2.61B)	(2.46B)	(2.58B)	(2.51B)	(2.58B)	[{"date":"2019-12-31","value":-261300000000,"profit":false},{"date":"2020-12-31","value":-246500000000,"profit":false},{"date":"2021-12-31","value":-257800000000,"profit":false},{"date":"2022-12-31","value":-250700000000,"profit":false},{"date":"2023-12-31","value":-258200000000,"profit":false}]
Pre-Tax Income	1.55B	3.92B	(265.00M)	2.50B	6.90B	[{"date":"2019-12-31","value":22.44,"profit":true},{"date":"2020-12-31","value":56.76,"profit":true},{"date":"2021-12-31","value":-3.84,"profit":false},{"date":"2022-12-31","value":36.25,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes	321.00M	772.00M	(380.00M)	(792.00M)	938.00M	[{"date":"2019-12-31","value":34.22,"profit":true},{"date":"2020-12-31","value":82.3,"profit":true},{"date":"2021-12-31","value":-40.51,"profit":false},{"date":"2022-12-31","value":-84.43,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes	1.23B	3.14B	115.00M	3.29B	5.96B	[{"date":"2019-12-31","value":20.58,"profit":true},{"date":"2020-12-31","value":52.74,"profit":true},{"date":"2021-12-31","value":1.93,"profit":true},{"date":"2022-12-31","value":55.24,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Income From Continuous Operations	1.23B	3.14B	115.00M	3.29B	5.96B	[{"date":"2019-12-31","value":20.58,"profit":true},{"date":"2020-12-31","value":52.74,"profit":true},{"date":"2021-12-31","value":1.93,"profit":true},{"date":"2022-12-31","value":55.24,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	1.33B	3.20B	112.00M	3.29B	5.96B	[{"date":"2019-12-31","value":22.42,"profit":true},{"date":"2020-12-31","value":53.67,"profit":true},{"date":"2021-12-31","value":1.88,"profit":true},{"date":"2022-12-31","value":55.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

EPS (Diluted)	1.77	2.02	2.65	3.34	3.63	[{"date":"2019-12-31","value":48.76,"profit":true},{"date":"2020-12-31","value":55.65,"profit":true},{"date":"2021-12-31","value":73,"profit":true},{"date":"2022-12-31","value":92.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	-	9.16%	40.58%	18.53%	3.29%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":22.57,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":45.67,"profit":true},{"date":"2023-12-31","value":8.11,"profit":true}]
Cost of Revenue	-	7.68%	134.70%	(0.37%)	(33.27%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":5.7,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.27,"profit":false},{"date":"2023-12-31","value":-24.7,"profit":false}]
Gross Profit	-	9.53%	17.18%	27.94%	17.47%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":34.11,"profit":true},{"date":"2021-12-31","value":61.48,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":62.52,"profit":true}]
Gross Margin	-	0.34%	(16.64%)	7.94%	13.72%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":2.49,"profit":true},{"date":"2021-12-31","value":-121.27,"profit":false},{"date":"2022-12-31","value":57.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	-	(0.67%)	48.08%	17.89%	2.19%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1.39,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":37.2,"profit":true},{"date":"2023-12-31","value":4.56,"profit":true}]
Operating Income	-	76.54%	(79.54%)	255.78%	118.07%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":29.92,"profit":true},{"date":"2021-12-31","value":-31.1,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":46.16,"profit":true}]
Total Non-Operating Income/Expense	-	(5.66%)	4.58%	(2.75%)	2.99%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-123.56,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-60.08,"profit":false},{"date":"2023-12-31","value":65.26,"profit":true}]
Pre-Tax Income	-	152.97%	(106.77%)	(1043.77%)	175.85%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":86.99,"profit":true},{"date":"2021-12-31","value":-60.71,"profit":false},{"date":"2022-12-31","value":-593.56,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes	-	140.50%	(149.22%)	108.42%	(218.43%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-106.21,"profit":false},{"date":"2022-12-31","value":77.17,"profit":true},{"date":"2023-12-31","value":-155.47,"profit":false}]
Income After Taxes	-	156.23%	(96.34%)	2763.48%	81.02%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":5.65,"profit":true},{"date":"2021-12-31","value":-3.49,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.93,"profit":true}]

Income From Continuous Operations	-	156.23%	(96.34%)	2763.48%	81.02%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":5.65,"profit":true},{"date":"2021-12-31","value":-3.49,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.93,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	139.40%	(96.50%)	2835.71%	81.11%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":4.92,"profit":true},{"date":"2021-12-31","value":-3.4,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.86,"profit":true}]

EPS (Diluted)	-	14.12%	31.19%	26.04%	8.68%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":45.29,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":83.49,"profit":true},{"date":"2023-12-31","value":27.84,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Revenue	10.88B	11.42B	11.49B	12.02B	12.68B	[{"date":"2023-03-31","value":85.8,"profit":true},{"date":"2023-06-30","value":90.04,"profit":true},{"date":"2023-09-30","value":90.64,"profit":true},{"date":"2023-12-31","value":94.83,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Cost of Revenue	1.91B	1.96B	2.10B	2.31B	2.22B	[{"date":"2023-03-31","value":82.54,"profit":true},{"date":"2023-06-30","value":84.92,"profit":true},{"date":"2023-09-30","value":90.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":96.1,"profit":true}]
Gross Profit	8.97B	9.46B	9.40B	9.72B	10.46B	[{"date":"2023-03-31","value":85.79,"profit":true},{"date":"2023-06-30","value":90.39,"profit":true},{"date":"2023-09-30","value":89.83,"profit":true},{"date":"2023-12-31","value":92.88,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Gross Margin	82.49%	82.83%	81.77%	80.81%	82.51%	[{"date":"2023-03-31","value":99.59,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":98.72,"profit":true},{"date":"2023-12-31","value":97.55,"profit":true},{"date":"2024-03-31","value":99.61,"profit":true}]

Operating Expenses	6.67B	7.00B	7.44B	7.71B	9.56B	[{"date":"2023-03-31","value":69.7,"profit":true},{"date":"2023-06-30","value":73.19,"profit":true},{"date":"2023-09-30","value":77.82,"profit":true},{"date":"2023-12-31","value":80.64,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Operating Income	2.55B	2.46B	1.95B	1.23B	3.12B	[{"date":"2023-03-31","value":81.83,"profit":true},{"date":"2023-06-30","value":78.84,"profit":true},{"date":"2023-09-30","value":62.73,"profit":true},{"date":"2023-12-31","value":39.61,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	(574.00M)	(735.00M)	(593.00M)	(680.00M)	-	[{"date":"2023-03-31","value":-57400000000,"profit":false},{"date":"2023-06-30","value":-73500000000,"profit":false},{"date":"2023-09-30","value":-59300000000,"profit":false},{"date":"2023-12-31","value":-68000000000,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Pre-Tax Income	2.26B	2.09B	1.65B	897.00M	2.80B	[{"date":"2023-03-31","value":80.79,"profit":true},{"date":"2023-06-30","value":74.57,"profit":true},{"date":"2023-09-30","value":59,"profit":true},{"date":"2023-12-31","value":32.04,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Income Taxes	458.00M	268.00M	274.00M	(62.00M)	-	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":58.52,"profit":true},{"date":"2023-09-30","value":59.83,"profit":true},{"date":"2023-12-31","value":-13.54,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Income After Taxes	1.80B	1.82B	1.38B	959.00M	-	[{"date":"2023-03-31","value":99.12,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":75.71,"profit":true},{"date":"2023-12-31","value":52.69,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]

Income From Continuous Operations	1.80B	1.82B	1.38B	959.00M	2.18B	[{"date":"2023-03-31","value":82.75,"profit":true},{"date":"2023-06-30","value":83.49,"profit":true},{"date":"2023-09-30","value":63.21,"profit":true},{"date":"2023-12-31","value":43.99,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income	1.80B	1.82B	1.37B	960.00M	2.18B	[{"date":"2023-03-31","value":82.74,"profit":true},{"date":"2023-06-30","value":83.43,"profit":true},{"date":"2023-09-30","value":63.06,"profit":true},{"date":"2023-12-31","value":44.06,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

EPS (Diluted)	0.96	1.08	0.87	0.72	1.03	[{"date":"2023-03-31","value":88.89,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":80.56,"profit":true},{"date":"2023-12-31","value":66.67,"profit":true},{"date":"2024-03-31","value":95.37,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Revenue	-	4.94%	0.67%	4.63%	5.45%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":90.61,"profit":true},{"date":"2023-09-30","value":12.22,"profit":true},{"date":"2023-12-31","value":84.98,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Cost of Revenue	-	2.89%	6.89%	10.17%	(3.90%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":28.4,"profit":true},{"date":"2023-09-30","value":67.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-38.35,"profit":false}]
Gross Profit	-	5.37%	(0.62%)	3.39%	7.67%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":70.05,"profit":true},{"date":"2023-09-30","value":-8.14,"profit":false},{"date":"2023-12-31","value":44.27,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Gross Margin	-	0.41%	(1.28%)	(1.18%)	2.11%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":19.69,"profit":true},{"date":"2023-09-30","value":-60.84,"profit":false},{"date":"2023-12-31","value":-56.04,"profit":false},{"date":"2024-03-31","value":100,"profit":true}]

Operating Expenses	-	5.01%	6.33%	3.61%	24.01%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":20.86,"profit":true},{"date":"2023-09-30","value":26.35,"profit":true},{"date":"2023-12-31","value":15.05,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Operating Income	-	(3.65%)	(20.44%)	(36.85%)	152.43%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-2.39,"profit":false},{"date":"2023-09-30","value":-13.41,"profit":false},{"date":"2023-12-31","value":-24.17,"profit":false},{"date":"2024-03-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	28.05%	(19.32%)	14.67%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-68.88,"profit":false},{"date":"2023-12-31","value":52.31,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Pre-Tax Income	-	(7.69%)	(20.88%)	(45.70%)	212.15%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-3.63,"profit":false},{"date":"2023-09-30","value":-9.84,"profit":false},{"date":"2023-12-31","value":-21.54,"profit":false},{"date":"2024-03-31","value":100,"profit":true}]
Income Taxes	-	(41.48%)	2.24%	(122.63%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-1852.98,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-5477.37,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Income After Taxes	-	0.89%	(24.29%)	(30.41%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-2738.21,"profit":false},{"date":"2023-12-31","value":-3428.32,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Income From Continuous Operations	-	0.89%	(24.29%)	(30.41%)	127.32%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":0.7,"profit":true},{"date":"2023-09-30","value":-19.07,"profit":false},{"date":"2023-12-31","value":-23.88,"profit":false},{"date":"2024-03-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income	-	0.83%	(24.42%)	(30.13%)	126.98%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":0.66,"profit":true},{"date":"2023-09-30","value":-19.23,"profit":false},{"date":"2023-12-31","value":-23.73,"profit":false},{"date":"2024-03-31","value":100,"profit":true}]

EPS (Diluted)	-	12.50%	(19.44%)	(17.24%)	43.06%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":29.03,"profit":true},{"date":"2023-09-30","value":-45.16,"profit":false},{"date":"2023-12-31","value":-40.04,"profit":false},{"date":"2024-03-31","value":100,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	15.56B	19.54B	26.24B	22.59B	25.05B	[{"date":"2019-12-31","value":59.3,"profit":true},{"date":"2020-12-31","value":74.47,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":86.09,"profit":true},{"date":"2023-12-31","value":95.47,"profit":true}]
Non-current Assets	45.81B	47.19B	79.12B	73.89B	76.06B	[{"date":"2019-12-31","value":57.91,"profit":true},{"date":"2020-12-31","value":59.64,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.39,"profit":true},{"date":"2023-12-31","value":96.14,"profit":true}]
Total Assets	61.38B	66.73B	105.36B	96.48B	101.12B	[{"date":"2019-12-31","value":58.25,"profit":true},{"date":"2020-12-31","value":63.33,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.57,"profit":true},{"date":"2023-12-31","value":95.97,"profit":true}]

Total Liabilities
Current Liabilities	18.12B	20.31B	22.59B	26.29B	30.54B	[{"date":"2019-12-31","value":59.32,"profit":true},{"date":"2020-12-31","value":66.49,"profit":true},{"date":"2021-12-31","value":73.98,"profit":true},{"date":"2022-12-31","value":86.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	28.66B	30.78B	43.48B	33.13B	31.41B	[{"date":"2019-12-31","value":65.92,"profit":true},{"date":"2020-12-31","value":70.8,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":76.2,"profit":true},{"date":"2023-12-31","value":72.24,"profit":true}]
Total Liabilities	46.78B	51.09B	66.08B	59.42B	61.95B	[{"date":"2019-12-31","value":70.8,"profit":true},{"date":"2020-12-31","value":77.32,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.93,"profit":true},{"date":"2023-12-31","value":93.76,"profit":true}]

Total Shareholders' equity
Common Stock	328.00M	328.00M	387.00M	387.00M	388.00M	[{"date":"2019-12-31","value":84.54,"profit":true},{"date":"2020-12-31","value":84.54,"profit":true},{"date":"2021-12-31","value":99.74,"profit":true},{"date":"2022-12-31","value":99.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	2.81B	5.30B	1.71B	(574.00M)	1.50B	[{"date":"2019-12-31","value":53.07,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":32.27,"profit":true},{"date":"2022-12-31","value":-10.83,"profit":false},{"date":"2023-12-31","value":28.34,"profit":true}]
Other Stockholders' Equity	8.39B	8.42B	35.57B	35.60B	35.64B	[{"date":"2019-12-31","value":23.54,"profit":true},{"date":"2020-12-31","value":23.62,"profit":true},{"date":"2021-12-31","value":99.83,"profit":true},{"date":"2022-12-31","value":99.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	13.13B	15.62B	39.27B	37.04B	39.14B	[{"date":"2019-12-31","value":33.43,"profit":true},{"date":"2020-12-31","value":39.78,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.32,"profit":true},{"date":"2023-12-31","value":99.68,"profit":true}]

Total Liabilities & Shareholders Equity	59.91B	66.71B	105.34B	96.46B	101.10B	[{"date":"2019-12-31","value":56.87,"profit":true},{"date":"2020-12-31","value":63.33,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.57,"profit":true},{"date":"2023-12-31","value":95.97,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	-	25.58%	34.28%	(13.91%)	10.89%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":74.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-40.58,"profit":false},{"date":"2023-12-31","value":31.77,"profit":true}]
Non-current Assets	-	2.99%	67.68%	(6.61%)	2.94%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":4.42,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-9.77,"profit":false},{"date":"2023-12-31","value":4.35,"profit":true}]
Total Assets	-	8.72%	57.90%	(8.43%)	4.80%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":15.06,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-14.56,"profit":false},{"date":"2023-12-31","value":8.3,"profit":true}]

Total Liabilities
Current Liabilities	-	12.09%	11.26%	16.37%	16.16%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":73.84,"profit":true},{"date":"2021-12-31","value":68.79,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.71,"profit":true}]
Non-current Liabilities	-	7.40%	41.25%	(23.80%)	(5.19%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":17.93,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-57.71,"profit":false},{"date":"2023-12-31","value":-12.59,"profit":false}]
Total Liabilities	-	9.21%	29.33%	(10.07%)	4.25%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":31.41,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-34.32,"profit":false},{"date":"2023-12-31","value":14.5,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	17.99%	-	0.26%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":1.44,"profit":true}]
Retained Earnings	-	88.44%	(67.73%)	(133.57%)	(361.67%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-76.58,"profit":false},{"date":"2022-12-31","value":-151.02,"profit":false},{"date":"2023-12-31","value":-408.94,"profit":false}]
Other Stockholders' Equity	-	0.36%	322.54%	0.08%	0.09%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":0.11,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.03,"profit":true},{"date":"2023-12-31","value":0.03,"profit":true}]
Total Shareholders' equity	-	19.01%	151.36%	(5.68%)	5.69%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":12.56,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-3.75,"profit":false},{"date":"2023-12-31","value":3.76,"profit":true}]

Total Liabilities & Shareholders Equity	-	11.36%	57.91%	(8.43%)	4.80%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":19.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-14.56,"profit":false},{"date":"2023-12-31","value":8.3,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Assets
Current Assets	22.27B	22.84B	22.50B	25.05B	25.59B	[{"date":"2023-03-31","value":87,"profit":true},{"date":"2023-06-30","value":89.24,"profit":true},{"date":"2023-09-30","value":87.92,"profit":true},{"date":"2023-12-31","value":97.89,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Non-current Assets	74.42B	73.70B	73.58B	76.06B	76.70B	[{"date":"2023-03-31","value":97.03,"profit":true},{"date":"2023-06-30","value":96.1,"profit":true},{"date":"2023-09-30","value":95.94,"profit":true},{"date":"2023-12-31","value":99.17,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Total Assets	96.69B	96.54B	96.09B	101.12B	102.29B	[{"date":"2023-03-31","value":94.52,"profit":true},{"date":"2023-06-30","value":94.38,"profit":true},{"date":"2023-09-30","value":93.93,"profit":true},{"date":"2023-12-31","value":98.85,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	24.86B	26.38B	28.59B	30.54B	28.90B	[{"date":"2023-03-31","value":81.4,"profit":true},{"date":"2023-06-30","value":86.36,"profit":true},{"date":"2023-09-30","value":93.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":94.63,"profit":true}]
Non-current Liabilities	36.02B	32.75B	30.28B	31.41B	35.89B	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":90.94,"profit":true},{"date":"2023-09-30","value":84.07,"profit":true},{"date":"2023-12-31","value":87.21,"profit":true},{"date":"2024-03-31","value":99.65,"profit":true}]
Total Liabilities	60.88B	59.13B	58.87B	61.95B	64.79B	[{"date":"2023-03-31","value":93.96,"profit":true},{"date":"2023-06-30","value":91.26,"profit":true},{"date":"2023-09-30","value":90.85,"profit":true},{"date":"2023-12-31","value":95.62,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	387.00M	387.00M	387.00M	388.00M	-	[{"date":"2023-03-31","value":99.74,"profit":true},{"date":"2023-06-30","value":99.74,"profit":true},{"date":"2023-09-30","value":99.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Retained Earnings	(1.82B)	(234.00M)	(434.00M)	1.50B	(212.00M)	[{"date":"2023-03-31","value":-121.5,"profit":false},{"date":"2023-06-30","value":-15.58,"profit":false},{"date":"2023-09-30","value":-28.89,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-14.11,"profit":false}]
Other Stockholders' Equity	35.16B	35.16B	35.17B	35.64B	-	[{"date":"2023-03-31","value":98.66,"profit":true},{"date":"2023-06-30","value":98.67,"profit":true},{"date":"2023-09-30","value":98.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Total Shareholders' equity	35.79B	37.39B	37.20B	39.14B	37.45B	[{"date":"2023-03-31","value":91.43,"profit":true},{"date":"2023-06-30","value":95.53,"profit":true},{"date":"2023-09-30","value":95.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":95.66,"profit":true}]

Total Liabilities & Shareholders Equity	96.67B	96.52B	96.06B	101.10B	102.24B	[{"date":"2023-03-31","value":94.55,"profit":true},{"date":"2023-06-30","value":94.41,"profit":true},{"date":"2023-09-30","value":93.96,"profit":true},{"date":"2023-12-31","value":98.88,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Assets
Current Assets	-	2.57%	(1.48%)	11.35%	2.16%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":22.68,"profit":true},{"date":"2023-09-30","value":-13.04,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":19,"profit":true}]
Non-current Assets	-	(0.96%)	(0.16%)	3.37%	0.83%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-28.59,"profit":false},{"date":"2023-09-30","value":-4.79,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":24.73,"profit":true}]
Total Assets	-	(0.15%)	(0.47%)	5.24%	1.16%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-2.84,"profit":false},{"date":"2023-09-30","value":-9.04,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":22.17,"profit":true}]

Total Liabilities
Current Liabilities	-	6.09%	8.39%	6.84%	(5.37%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":72.63,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":81.46,"profit":true},{"date":"2024-03-31","value":-64.04,"profit":false}]
Non-current Liabilities	-	(9.06%)	(7.56%)	3.75%	14.26%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-63.54,"profit":false},{"date":"2023-09-30","value":-52.98,"profit":false},{"date":"2023-12-31","value":26.26,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Total Liabilities	-	(2.87%)	(0.44%)	5.25%	4.58%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-54.77,"profit":false},{"date":"2023-09-30","value":-8.45,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":87.35,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	0.26%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Retained Earnings	-	(87.18%)	85.47%	(446.08%)	(114.11%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-102,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-521.92,"profit":false},{"date":"2024-03-31","value":-133.51,"profit":false}]
Other Stockholders' Equity	-	0.01%	0.01%	1.34%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":0.85,"profit":true},{"date":"2023-09-30","value":0.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Total Shareholders' equity	-	4.48%	(0.52%)	5.23%	(4.34%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":85.61,"profit":true},{"date":"2023-09-30","value":-9.97,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-82.92,"profit":false}]

Total Liabilities & Shareholders Equity	-	(0.15%)	(0.47%)	5.24%	1.13%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-2.88,"profit":false},{"date":"2023-09-30","value":-9.04,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":21.54,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	2.97B	4.80B	5.96B	9.81B	10.35B	[{"date":"2019-12-31","value":28.7,"profit":true},{"date":"2020-12-31","value":46.39,"profit":true},{"date":"2021-12-31","value":57.64,"profit":true},{"date":"2022-12-31","value":94.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	(657.00M)	(285.00M)	(11.06B)	(2.96B)	(4.06B)	[{"date":"2019-12-31","value":-65700000000,"profit":false},{"date":"2020-12-31","value":-28500000000,"profit":false},{"date":"2021-12-31","value":-1105800000000,"profit":false},{"date":"2022-12-31","value":-296000000000,"profit":false},{"date":"2023-12-31","value":-406400000000,"profit":false}]

Financing Activities
Net Financing Cash Flow	(1.76B)	(2.20B)	3.65B	(6.82B)	(6.57B)	[{"date":"2019-12-31","value":-48.37,"profit":false},{"date":"2020-12-31","value":-60.37,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-186.98,"profit":false},{"date":"2023-12-31","value":-179.97,"profit":false}]

Net Change in Cash	552.00M	2.32B	(1.51B)	(55.00M)	(346.00M)	[{"date":"2019-12-31","value":23.76,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-64.92,"profit":false},{"date":"2022-12-31","value":-2.37,"profit":false},{"date":"2023-12-31","value":-14.89,"profit":false}]

Free Cash Flow
Free Cash Flow	509.00M	2.19B	3.76B	7.24B	6.57B	[{"date":"2019-12-31","value":7.03,"profit":true},{"date":"2020-12-31","value":30.3,"profit":true},{"date":"2021-12-31","value":52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.74,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	-	61.64%	24.26%	64.48%	5.48%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":95.59,"profit":true},{"date":"2021-12-31","value":37.62,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":8.49,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(56.62%)	3780.00%	(73.23%)	37.30%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1.5,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1.94,"profit":false},{"date":"2023-12-31","value":0.99,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	24.82%	(265.64%)	(286.98%)	(3.75%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1070.44,"profit":false},{"date":"2022-12-31","value":-1156.45,"profit":false},{"date":"2023-12-31","value":-15.12,"profit":false}]

Net Change in Cash	-	320.83%	(164.92%)	(96.35%)	529.09%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":60.64,"profit":true},{"date":"2021-12-31","value":-31.17,"profit":false},{"date":"2022-12-31","value":-18.21,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	330.84%	71.59%	92.32%	(9.26%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":21.64,"profit":true},{"date":"2022-12-31","value":27.9,"profit":true},{"date":"2023-12-31","value":-2.8,"profit":false}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Operating Activities
Net Operating Cash Flow	3.13B	1.72B	3.11B	2.38B	2.49B	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":54.84,"profit":true},{"date":"2023-09-30","value":99.39,"profit":true},{"date":"2023-12-31","value":75.97,"profit":true},{"date":"2024-03-31","value":79.35,"profit":true}]

Investing Activities
Net Investing Cash Flow	(1.25B)	(520.00M)	(1.22B)	(1.08B)	-	[{"date":"2023-03-31","value":-124600000000,"profit":false},{"date":"2023-06-30","value":-52000000000,"profit":false},{"date":"2023-09-30","value":-122100000000,"profit":false},{"date":"2023-12-31","value":-107700000000,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	(2.03B)	(1.52B)	(2.73B)	(291.00M)	-	[{"date":"2023-03-31","value":-203100000000,"profit":false},{"date":"2023-06-30","value":-151900000000,"profit":false},{"date":"2023-09-30","value":-272600000000,"profit":false},{"date":"2023-12-31","value":-29100000000,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Net Change in Cash	(155.00M)	(357.00M)	(852.00M)	1.02B	2.10B	[{"date":"2023-03-31","value":-7.38,"profit":false},{"date":"2023-06-30","value":-16.99,"profit":false},{"date":"2023-09-30","value":-40.55,"profit":false},{"date":"2023-12-31","value":48.45,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	1.66B	1.24B	2.23B	1.43B	881.00M	[{"date":"2023-03-31","value":74.41,"profit":true},{"date":"2023-06-30","value":55.26,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":64.16,"profit":true},{"date":"2024-03-31","value":39.42,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Operating Activities
Net Operating Cash Flow	-	(45.16%)	81.26%	(23.57%)	4.45%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-55.58,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-29.01,"profit":false},{"date":"2024-03-31","value":5.48,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(58.27%)	134.81%	(11.79%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-43.22,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-8.75,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(25.21%)	79.46%	(89.33%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-31.73,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-112.41,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Net Change in Cash	-	130.32%	138.66%	(219.48%)	106.39%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":93.99,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-158.29,"profit":false},{"date":"2024-03-31","value":76.73,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(25.74%)	80.97%	(35.84%)	(38.56%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-31.78,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-44.26,"profit":false},{"date":"2024-03-31","value":-47.63,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	AZN
Current Ratio	0.89
Quick Ratio	0.70

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	AZN
ROA (LTM)	7.04%
ROE (LTM)	17.29%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	AZN
Debt Ratio Lower is generally better. Negative is bad.	0.63
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.37
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is.	2.73

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	AZN
Trailing PE	37.83
Forward PE	16.31
P/S (TTM)	4.67
P/B	5.46
Price/FCF	269
EV/R	5.20
EV/Ebitda	17.74
PEG	1.08

News

Ait Taleb denies fatal AstraZeneca vaccine side effects, stresses non-privatization of healthcare facilities

Morocco’s Health Minister Khalid Ait Taleb denied any “fatal side effects” from the AstraZeneca vaccine, stressing that “the company – while the reason for people’s concern and delving into the subject at this particular time is unknown – only spoke in its statement about very rare side effects.” “Even the World Health Organization (WHO) has not talked about this subject as it considers it outdated, and because it has already approved the use of the vaccines in question,” added the Health Minister, in a statement to Hespress Ar to mark the halfway point of the government’s term. He stressed that “there’s no drug or vaccine without side effects.” Ait Taleb underscored “since the early days of using AstraZeneca or other vaccines, their potential side effects have been well-publicized, including blood clots and thrombocytopenia in some people with strong immune systems that react strongly to the vaccine, particularly among younger individuals.” The Miniter explained that “the vaccine’s benefits are proven and outweigh the risks and their impact;” that’s why the WHO authorized and approved its use, as it has with all other vaccines.” The organization, he added, has issued a recommendation, stating that “the AstraZeneca and Johnson & Johnson vaccines may activate an anti-platelet mechanism, leading to a decrease in platelets.

4 May, 2024 a 4:00 pm Hespress English

News wrap: Covishield side effects, Google fires Python team, Rahul Gandhi''s nomination from Raebareli and more

Top news of the week: AstraZeneca admits rare blood clot risk; Rahul Gandhi files nomination from Raebareli for Lok Sabha Election; Adani Ports Q4 net profit jumps 76% YoY; Google fires entire Python team, and more

4 May, 2024 a 5:29 am Livemint

Queries on Covishield side effects reach docs after AstraZeneca report

Worried Covid survivors in Kolkata have been calling up doctors and hospitals following pharmaceutical company AstraZeneca’s admission in a UK court that its Covid-19 vaccine Covishield has the potential to cause thrombosis with thrombocytopenia syndrome (TTS). Learn more about the side effects and concerns surrounding Covishield in this article.

3 May, 2024 a 11:19 pm The Times of India

India: Parents to sue AstraZeneca over daughter’s alleged death due to Covishield vaccine

The parents of a young woman who allegedly died after taking AstraZenecaâs COVID-19 vaccine, Covishield, are planning to file a lawsuit against the

3 May, 2024 a 7:13 pm WION

Couple to sue Serum Institute over daughter’s death after taking Covishield

GUWAHATI, MAY 3: Following UK pharmaceutical giant AstraZeneca’s admission in court documents that the COVID vaccine Covishield is likely to cause rare side effects, the parents of a young woman who allegedly died after being vaccinated with Covishield are planning to file a lawsuit against the world’s largest vaccine maker as well as the British pharma giant that developed it during the pandemic. According to reports, Venugopal Govindan lost his 20-year-old daughter, Karunga, in 2021 due to alleged complications related to vaccination. In a post on the microblogging site X, Govindan said, “As a responsible manufacturer, AstraZeneca, and its Indian Manufacturer, Serum Institute should have stopped the manufacture and supply of these vaccines when 15 European countries either suspended or age limited these vaccines due to the deaths from blood clots that happened in 2021 March, within couple of months of the rollout of the vaccine itself.” While echoing the sentiments of other parents who have lost their children, Govindan added, “The grieving parents are fighting for justice in various courts and for reasons best known to our judicial system we are not getting a hearing for our cases.

3 May, 2024 a 2:17 pm Nagaland Page

AstraZeneca Finally Admits That Its COVID-19 Vaccine Can Cause Deadly Blood Clots

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name (only available in desktop version). To receive Global Research’s Daily Newsletter (selected articles), click here . Click the share button … The post AstraZeneca Finally Admits That Its COVID-19 Vaccine Can Cause Deadly Blood Clots appeared first on Global Research .

3 May, 2024 a 2:16 pm The Centre for Research on Globalization (CRG)

AstraZeneca launches Cancer Care Africa program in Kenya to boost equitable access to care

AstraZeneca launched an innovative cancer care Africa program which will help patients in Kenya gain better and more fair access to cancer care. The UK Pharma launched Cancer Care Africa program in Nairobi in collaboration with the Ministry of Health, The Kenya Society of Hematology and Oncology (KESHO), Axios, the National Cancer Institute of Kenya […]

3 May, 2024 a 12:27 pm Health Business Kenya

Side effects of AstraZeneca vaccine: Medicine is clear now to the courts

Benefits of Covid vaccines war outweigh risks. Pandemic has created ethical dilemmas. The way court''s resolve them could impact people''s perception of vaccines

3 May, 2024 a 11:58 am The Indian Express

Families ''give up legal action'' against Astrazeneca after Covid vaccine blood clot deaths

Twelve families have dropped their cases, according to reports

3 May, 2024 a 8:40 am Evening Standard

Parents To Sue AstraZeneca Over Daughter''s Covishield Vaccine-Linked Death

… legal action against the British pharma company that manufactured the vaccine … compensation for affected families. Meanwhile, AstraZeneca is currently facing a class … . The UK government, having indemnified AstraZeneca against legal actions related to …

3 May, 2024 a 7:20 am EIN News Pharmaceuticals

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is AstraZeneca PLC ADR share price today?

AstraZeneca PLC ADR (AZN) share price today is $76.35

Can Indians buy AstraZeneca PLC ADR shares?

Yes, Indians can buy shares of AstraZeneca PLC ADR (AZN) on Vested. To buy AstraZeneca PLC ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AZN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AstraZeneca PLC ADR be purchased?

Yes, you can purchase fractional shares of AstraZeneca PLC ADR (AZN) via the Vested app. You can start investing in AstraZeneca PLC ADR (AZN) with a minimum investment of $1.

How to invest in AstraZeneca PLC ADR shares from India?

You can invest in shares of AstraZeneca PLC ADR (AZN) via Vested in three simple steps:

Click on Sign Up or Invest in AZN stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in AstraZeneca PLC ADR shares

What is AstraZeneca PLC ADR 52-week high and low stock price?

The 52-week high price of AstraZeneca PLC ADR (AZN) is $76.8. The 52-week low price of AstraZeneca PLC ADR (AZN) is $59.55.

What is AstraZeneca PLC ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of AstraZeneca PLC ADR (AZN) is 37.61

What is AstraZeneca PLC ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AstraZeneca PLC ADR (AZN) is 5.46

What is AstraZeneca PLC ADR dividend yield?

The dividend yield of AstraZeneca PLC ADR (AZN) is 1.9%

What is the Market Cap of AstraZeneca PLC ADR?

The market capitalization of AstraZeneca PLC ADR (AZN) is $236.72B

What is AstraZeneca PLC ADR’s stock symbol?

The stock symbol (or ticker) of AstraZeneca PLC ADR is AZN

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

AstraZeneca PLC ADR, Common Stock

AZN

NSQ

$76.35

+$0.55

(0.73%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About AstraZeneca PLC ADR, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

News

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²